The popularity of Viagra initially fueled a boom for major pharmaceutical companies, nevertheless recent shifts present a murky picture for investors. Generic versions are eating into revenue, and continued patent https://franceszrwc064238.blogars.com/39674619/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-play